Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,859 | -296 | -1 | -697 | N/A |
| Depreciation Amortization | 185 | 78 | N/A | 28 | N/A |
| Accounts receivable | N/A | N/A | N/A | -10 | N/A |
| Other Working Capital | 121 | 33 | 1 | 200 | N/A |
| Other Operating Activity | 1,122 | 0 | 0 | 437 | 0 |
| Operating Cash Flow | $-431 | $-186 | $0 | $-42 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 794 | 222 | N/A | N/A | N/A |
| Common Stock Issued | 20 | 0 | N/A | 50 | N/A |
| Other Financing Activity | -250 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $564 | $222 | $N/A | $50 | $N/A |
| Beginning Cash Position | 36 | 0 | N/A | 4 | N/A |
| End Cash Position | 170 | 36 | 0 | 11 | N/A |
| Net Cash Flow | $133 | $36 | $0 | $8 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -431 | -186 | 0 | -42 | N/A |
| Free Cash Flow | -431 | -186 | 0 | -42 | 0 |